Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Orion, an European R&D-based pharmaceutical and diagnostic company, has signed a deal with Nycomed to jointly market Easyhaler combination products as a treatment for asthma and chronic obstructive pulmonary disease (COPD) in some of the European countries.
Subscribe to our email newsletter
The agreement covers Switzerland, Italy, Austria, the Benelux countries, Germany, France, Poland, Greece, Portugal, Spain and other European nations.
Additionally, the companies have also signed a licensing and distribution agreement for Easyhaler combination products in the Middle East and North African region (MENA).
The agreement allows Orion to hold the marketing rights for Easyhaler combination products in the Nordic countries, UK and Eastern Europe where the company is currently promoting single molecule Easyhaler products.
Orion will exclusively manufacture the Easyhaler combination products covered by the agreement.